Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.5 USD | +1.77% | +8.91% | +30.25% |
01:15pm | HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target | MT |
May. 09 | Lexeo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.25% | 566M | |
+55.29% | 59.34B | |
+43.17% | 40.24B | |
-5.09% | 39.88B | |
-5.56% | 28.55B | |
+14.75% | 27.26B | |
-21.68% | 19.23B | |
+31.53% | 12.61B | |
+2.13% | 12.49B | |
+25.71% | 12.28B |
- Stock Market
- Equities
- LXEO Stock
- News Lexeo Therapeutics, Inc.
- Chardan Initiates Lexeo Therapeutics With Buy Rating, $23 Price Target